You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 135 No. 9, September 2009 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Sleep Apnea
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

First-Choice Treatment in Mild to Moderate Obstructive Sleep Apnea

Single-Stage, Multilevel, Temperature-Controlled Radiofrequency Tissue Volume Reduction or Nasal Continuous Positive Airway Pressure

Kursat Ceylan, MD{dagger}; Hatice Emir, MD; Zeynep Kizilkaya, MD; Eren Tastan, MD; Ahmet Yavanoglu, MD; Hakki Uzunkulaoglu, MD; Erdal Samim, MD; Sevim Arslan Felek, MD

Arch Otolaryngol Head Neck Surg. 2009;135(9):915-919.

Objective  To compare the efficacy of single-stage, multilevel, temperature-controlled radiofrequency tissue volume reduction (TCRFTVR) for the soft palate and base of the tongue with that of nasal continuous positive airway pressure (CPAP) in primary treatment of mild to moderate obstructive sleep apnea.

Design  A prospective nonrandomized clinical study.

Setting  Tertiary care referral center.

Patients  Data from 47 patients with mild to moderate obstructive sleep apnea treated between January 1, 2003, and October 31, 2006, were reviewed.

Interventions  Twenty-six patients underwent TCRFTVR and 21 underwent nasal CPAP as a primary treatment modality.

Main Outcome Measures  Baseline and 12-month posttreatment measurements using the Epworth Sleepiness Scale and polysomnography were compared.

Results  The baseline characteristics of the groups were not significantly different. Both methods showed meaningful results for the Epworth Sleepiness Scale and polysomnography variables 12 months after treatment compared with baseline measurements. The results were not significantly different in the posttreatment intergroup comparisons. Treatment success rates were 52.4% for nasal CPAP and 53.8% for TCRFTVR (P = .92).

Conclusion  Similar comparison results with nasal CPAP in objective and subjective variables make single-stage, multilevel TCRFTVR a good alternative in primary treatment of mild to moderate obstructive sleep apnea.



Author Affiliations: Ear, Nose, and Throat Department, Ministry of Health, Ankara Training and Research Hospital, Ankara, Turkey.
{dagger}Deceased.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.